Literature DB >> 19958290

Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?

Alvin Eisner1, Shaban Demirel.   

Abstract

PURPOSE: To determine whether the hill of vision for Short-Wavelength Automated Perimetry (SWAP) is shallower for women who consume phyto-oestrogen-rich foods than for women who do not.
METHODS: Visual field data were compared for two groups of healthy amenorrhoeic women 48-69 years-old with normal vision and not using hormone replacement: (1) 24 subjects who reported consuming soy and/or flax products and (2) 20 subjects who reported not consuming these products. Two types of 24-2 visual fields were measured: (1) Full Threshold SWAP and (2) a white-on-white (W/W) field obtained using a Swedish Interactive Threshold Algorithm (SITA Standard).
RESULTS: The reduction of SWAP sensitivity from the centre of the field (4 loci, mean eccentricity = 4.2°) to the periphery (20 loci, mean eccentricity = 21.9°) was less for soy/flax consumers than for nonconsumers, both with age-referencing (mean difference = 1.7 dB, p = 0.018) and without (p = 0.012). Corresponding distinctions existed for the SWAP - W/W difference, and there was minimal effect for W/W fields alone. The peripheral age-referenced SWAP sensitivities averaged 2.5 dB higher for consumers than nonconsumers (p = 0.022).
CONCLUSION: The between-group distinctions are consistent with the possibility (derived from the women's health literature) that phyto-oestrogens may counteract a decline of short-wavelength-sensitive cone-mediated response among postmenopausal women. These results suggest another potential application for SWAP outside its original intended purpose as a glaucoma test. Future studies should assess whether phyto-oestrogen consumption is most beneficial for women who are sufficiently young and/or not too far beyond menopause.
© 2009 The Authors. Journal compilation © 2009 Acta Ophthalmol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19958290      PMCID: PMC2888924          DOI: 10.1111/j.1755-3768.2009.01799.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  61 in total

1.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging.

Authors:  S D Harlow; S Crawford; L Dennerstein; H G Burger; E S Mitchell; M-F Sowers
Journal:  Climacteric       Date:  2007-04       Impact factor: 3.005

Review 3.  Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

Authors:  M Morissette; M Le Saux; M D'Astous; S Jourdain; S Al Sweidi; N Morin; E Estrada-Camarena; Pablo Mendez; Luis Miguel Garcia-Segura; T Di Paolo
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

4.  The color appearance of stimuli detected via short-wavelength-sensitive cones: comparisons with visual adaptation and visual field data for peri- or post-menopausal women under 70 years of age.

Authors:  Alvin Eisner; Maureen D Toomey
Journal:  Vision Res       Date:  2008-03-17       Impact factor: 1.886

5.  Luminance and opponent-color contributions to visual detection and adaptation and to temporal and spatial integration.

Authors:  P E King-Smith; D Carden
Journal:  J Opt Soc Am       Date:  1976-07

Review 6.  Assessing exposure to lignans and their metabolites in humans.

Authors:  Johanna W Lampe; Charlotte Atkinson; Meredith A J Hullar
Journal:  J AOAC Int       Date:  2006 Jul-Aug       Impact factor: 1.913

7.  Visual fields correlate better than visual acuity to severity of diabetic retinopathy.

Authors:  B Bengtsson; A Heijl; E Agardh
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

8.  Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA.

Authors:  H S Cui; L S Huang; D-E Sok; J Shin; B-M Kwon; U J Youn; K Bae
Journal:  Phytomedicine       Date:  2007-04-30       Impact factor: 5.340

Review 9.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

10.  Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.

Authors:  Alvin Eisner; Maureen D Toomey; Julie Falardeau; John R Samples; John T Vetto
Journal:  Breast Cancer Res Treat       Date:  2007-01-27       Impact factor: 4.872

View more
  2 in total

Review 1.  Breast cancer medications and vision: effects of treatments for early-stage disease.

Authors:  Alvin Eisner; Shiuh-Wen Luoh
Journal:  Curr Eye Res       Date:  2011-08-05       Impact factor: 2.424

Review 2.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.